We support our clients in aligning common interests of all relevant stakeholders to tangibly shape healthcare systems towards more sustainability.
- Governments and regulators are second only to traditional customers in their ability to affect pharma companies’ economic value. Specifically, policy makers have a significant impact on access to innovative care through the issuing of austerity measures, for example.
- In addition, the majority of policy makers and influencers do not yet see pharma companies as their partners in shaping the future of sustainable healthcare. This has been fueled by biased approaches to lobbying in the past as well as a lack of co-creation based on trusting relationships.
- Also, internal Government Affairs functions within pharma companies are often buried under a support function with limited understanding from business leaders on what they do.
- Government Affairs needs to demonstrate how strategic communication and stakeholder engagement activities support business objectives and how the achievement of favorable government policies and payer environments enable sustainable business growth.